baber/WOPTO huggingface dataset:
Patent IL-140165-A0 (IL)
Title: Device for determining an analyate in a liquid sample
IPC: G01N33/543
Filed: 1999-06-10
Abstract: The invention concerns a device for determining an analyte in a liquid sample, comprising: a) a gripping support (1); b) first capillary diffusing means (2) integral with the gripping support (1) comprising a downstream zone (2a) accessible to external observation; c) a set of predetermined reagents for detecting and/or quantifying the analyte; d) a member for collecting (4) the liquid sample mounted on the support (1). The invention is characterized in that the member for collecting (4) the liquid sample is mounted mobile or fixed on the support; second capillary diffusion means (41) extends from a zone collecting (41a) said sample, to a zone transferring (41b) the latter; and an upstream zone (2b) of said first capillary diffusion means (2) is arranged to be urged temporarily to constitute continuous capillary flow with the second diffusion means (41) transferring zone (41b), when the collecting member (4) is in the retracted position.
Patent IL-143165-A0 (IL)
Title: Elecric motor cooled by a fluid and having high specific power
IPC: H02K3/47
Filed: 1999-11-26
Abstract: Disclosed is a micromotor with a motor housing (20) formed of polymer material. Said motor housing (20) surrounds the stator (24). The motor drives a pump part (12), which pushes fluid along the motor housing (20). The polymer material of the motor housing (20) contains an electrically isolating filler having caloric conductibility, especially Al2O3. Thereby, the temperatures arising in the motor housing are reduced. Furthermore, the hollow spaces of the coils (24a) of the stator can be filled up with a polymer material which contains a filler with caloric conductibility. The internal temperature of the motor is reduced as a result of the heat carried away to the fluid flowing around the motor. The micromotor is particularly useful for an intravascular blood pump.
Patent IL-143778-A0 (IL)
Title: Transparent transdermal nicotine delivery devices
IPC: A61P25/34
Filed: 1999-12-14
Abstract: A device for the transdermal administration of nicotine comprises a backing layer, a drug reservoir layer containing nicotine carried by said backing layer, and means for maintaining the device in nicotine transmitting relationship with the skin. The the device absorbs less than 48.6% of incidental light passing through the device so as to permit the natural skin colour of the subject to whom the device is applied to be visible through said device, and is effective for nicotine replacement therapy under exposure of the device to light.
Patent IL-146191-A0 (IL)
Title: Viral expression vectors
IPC: C12N15/09
Filed: 2000-05-04
Abstract: The present invention provides nucleic acid sequences having an altered viral movement protein and 126/183 kDa replicase proteins further characterized in its ability tostabilize a transgene contained in a virus that expresses the altered movement protein. The present invention also provides viral vectors expressing the altered movement protein, cells transformed with the vectors, and host plants infected by the viral vectors.
Patent IL-149647-A0 (IL)
Title: Processes for production of oxadiazoline derivatives
IPC: C07D413/04
Filed: 2000-11-17
Abstract: A process as represented by reaction scheme: <CHEM> which permits industrial mass production of  DELTA <2>-1,2,4-oxadiazoline derivatives having excellent insecticidal effects or salts thereof in high yield with advantage, Äwherein X<1> is halogeno; R<1> is optionally substituted alkyl, optionally substituted acyl, or ClCO; R<2> is (1) halogeno, (2) C1-6 haloalkyl, (3) C1-6 haloalkoxy, or (4) phenyl optionally substituted with C1-6 haloalkyl; A is nitrogen or =CR<3>- (wherein R<3> is Cl or CN) ; R<4> is C1-6 alkyl or C1-6 haloalkyl; n is 0, 1 or 2; and X<2> is halogenoÜ.
Patent IL-150646-A0 (IL)
Title: Benzodioxinothiophenes, their preparation and use
IPC: H01M10/0565
Filed: 2002-07-09
Abstract: Novel benzodioxythiophene compounds are claimed. <??>Novel benzodioxythiophene compounds (I) of formula (1) are claimed. <??>R<1>,R<2> = H, 1-20C alkyl, 6-10C aryl, 7-12 aralkyl, 1-18C alkoxy, 2-18C hydroxyalkylenoxy, 2-36C alkoxyalkylenoxy, hydroxyethyl, formyl, 2-18C acyl, nitro, halogen, -SO3H, -CN, -COOH, 1-18C alkoxycarbonyl or trifluoromethyl or together with the aromatic ring form an annealed aromatic ring system; <??>X = N or C-H <??>Independent claims are included for: <??>(i) a process for the production of formula (1) by reaction of a 3,4-dialkoxythiophene compound with an optionally substituted 1,2-dihydroxybenzene compound; <??>(ii) an electrically conductive polymer comprising compounds (I) as repeating units.
Patent IL-153375-A0 (IL)
Title: Agonist anti-trk-c monoclonal antibodies
IPC: A61P9/00
Filed: 2001-06-22
Abstract: The invention concerns agonist anti-trkC monoclonal antibodies which mimic certain biological activities of NT-3, the native ligand of trkC. The invention further concerns the use of such antibodies in the prevention and/or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy.
Patent IL-160659-A0 (IL)
Title: Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
IPC: G01N33/577
Filed: 2002-09-04
Abstract: Methods and compositions for the development of effective cancer therapies using mitotic inhibitors which have limited general toxicity to normal, non-cancerous cells and tissues are provided. The methods and compositions utilize cytotoxic compounds comprised of a cell-binding agent (e.g., antibodies) conjugated to an anti-mitotic compound (e.g., maytansinoids). The invention further provides antibodies which are substantially incapable of inducing antibody-dependent cell-mediated cytotoxicity (ADCC) and/or complement dependent cytotoxicity (CDC), thereby ensuring that the therapeutic effect is mediated primarily by the anti-mitotic component of the cytotoxic compound, rather than by indirect cell killing via ADCC and/or CDC. The antibodies of the invention further are capable of differentiating between polypeptide antigens which are more highly expressed on proliferating cancer cells as compared to proliferating non-cancer cells.
Patent IL-161017-A0 (IL)
Title: Ceasing transmission of data rate control information in a cdma communication system when the mobile station transits to the idle open state
IPC: H04B7/26
Filed: 2002-09-24
Abstract: In a communication system, a method and an apparatus provide for efficient communications of data rate control information. A mobile station communicates a request on a data channel for reception of a data file on a traffic channel. The mobile station communicates data rate control information on a data rate control channel. The communication of data rate control information on the data rate control channel is ceased if the delivery of the data file on the traffic channel from a base station to the mobile station or a reverse traffic channel from the mobile station to the base station is concluded.
Patent IL-162419-A0 (IL)
Title: Methods, devices, and preparations for intervertebral disc treatment
IPC: A61L31/04
Filed: 2002-12-10
Abstract: A therapeutic method for treating mammalian intervertebral discs. A preparation of cross-linked collagen is injected under pressure into the intra-discal space. The intervertebral distance in injected discs is immediately increased by the treatment. At least some mechanical properties of the treated vertebral column are preserved or partially restored. The method may be used to relieve back pain in patients, to increase patient height and to stabilized the spinal column. The therapeutic method may result in at least a partial regeneration of the nucleus pulposus, and/or development of cartilaginous or fibrocartilaginous tissues or dense fibrous tissues.
Patent IL-171907-A0 (IL)
Title: Processing a security massage authentication control instruction
IPC: G06F9/302
Filed: 2005-11-10
Abstract: A method, system and computer program product for computing a message authentication code for data in storage of a computing environment. An instruction specifies a unit of storage for which an authentication code is to be computed. An computing operation computes an authentication code for the unit of storage.
Patent IL-173318-A0 (IL)
Title: An armour plate
IPC: F41H5/04
Filed: 2006-01-24
Abstract: Several ceramic armour systems are provided herein. One such system is a ceramic armour system for personnel. Such system includes an integral ceramic plate, or a plurality of interconnected ceramic components providing an integral plate. The ceramic has a deflecting front surface or a flat front surface, and a rear surface. A front spall layer is bonded to the front surface of the ceramic plate. A shock-absorbing layer is bonded to the rear surface of ceramic plate. A backing is bonded to the exposed face of the shock-absorbing layer. A second such system is a ceramic armour system for vehicles. Such system also includes an integral ceramic plate, or a plurality of interconnected ceramic components providing an integral plate. The ceramic plate has a deflecting front surface or a flat front surface, and a rear surface. A front spall layer is bonded to the front surface of the ceramic plate. A shock-absorbing layer is bonded to the rear surface of the ceramic plate. The assembly of the front spall layer, the ceramic plate, and the shock-absorbing layer is bolted to the hull of a vehicle, preferably with an air gap, or alternatively without an air gap.
Patent IL-183401-A0 (IL)
Title: Compositions comprising ornithine and phenylacetate of phenylbutyrate for treating hepatic encephalopathy
Filed: 2007-05-24
Abstract: The present invention relates to use of ornithine in the manufacture of a medicament for use in combination with at least one of phenylacetate and phenylbutyrate for preventing or treating hyperammonemia. The invention also relates to use of at least one of phenylacetate and phenylbutyrate in the manufacture of a medicament for use in combination with ornithine for preventing or treating hyperammonemia.
Patent IL-186793-A0 (IL)
Title: Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
Filed: 2007-10-18
Abstract: The invention provides compositions and methods for the treatment of diseases associated with amyloid deposits of A² in the brain of a patient, such as Alzheimer's disease. Such methods entail administering an immunogenic fragment of A², lacking a T-cell epitope, capable of inducing a beneficial immune response in the form of antibodies to A². In another aspect, the immunogenic fragment of A² is capable of elevating plasma A² levels. The immunogenic fragments comprise linear or multivalent peptides of A². Pharmaceutical compositions comprise the immunogenic fragment chemically linked to a carrier molecule which may be administered with an adjuvant.
Patent RO-128031-A0 (RO)
Title: Method for producing thin lead-free perovskite sodium bismuth titanate (nabitio) films with high dielectric properties
Inventor: SCARISOREANU NICU DOINEL
IPC: C23C16/42
Filed: 2011-12-09
Abstract: The invention relates to a process for producing thin lead-free perovskite sodium bismuth titanate NaBiTiO, (abbreviated NBT ) films with morphological, structural, optical and dielectrical characteristics compatible with the low frequency electronic applications based on the silicon technology, by using the pulsed laser deposition technique. According to the invention, the process consists in depositing thin sodium bismuth titanate, NaBiTiO, films onto a silicon target substrate metallized with a layer of platinum with a thickness of 100 nm by using the pulsed laser technique, wherefrom there results a coating of NBT/Pt/Si with a total thickness of 417.272 ± 3.57 nm, having a value of the forbidden band-width of 3.8 ± 0.05 eV, the values of the dielectric losses lower than 0.05 and the values of the dielectric permittivity of 1450 at 10 kHz.
Patent RO-137234-A0 (RO)
Title: Unmanned aircraft made of composite materials using additive manufacturing technologies
Inventor: ZAHARIA SEBASTIAN MARIAN
IPC: B64C39/00
Filed: 2022-09-19
Abstract: The invention relates to an unmanned aircraft made of composite materials using additive manufacturing technologies, intended for search and rescue missions. According to the invention, the aircraft consists of a fuselage (1), two wings (2) on which are mounted propulsion systems (3) consisting of two electric motors, a main landing gear (4) and a tail skid (5), a fixed horizontal fin consisting of a stabilizer (6) and a depth rudder (7), a vertical tail assembly consisting of a fin (8) and a rudder (9), some flaps (10), some ailerons (11) and winglets (12), a thermal imaging camera (13) and a flight control system (14).
Patent RO-137641-A0 (RO)
Title: Natural wound healer for anal fissure treatment
Inventor: MATRAN IRINA MIHAELA
IPC: A61K9/06
Filed: 2023-04-24
Abstract: The invention relates to a natural wound healer for anal fissure treatment, to be used in medicine and pharmacy. According to the invention, the healer cream is a mixture of the following components: 0.1...25% cold-pressed oil of Persea Americana, 0.1...20% cold-pressed oil of Helianthus annuus, 0.1...11% oil of Ricinus communis, 0.1...2% oily extract of Hypericum perforatum, 0.1...5% essential oil of Thymus vulgaris, 0.1...5% essential oil of Anethum graveolens, 0.1...5% oil of Salvia officinalis, 0.1...3% oil of Mentha piperita, 0.1...5% oil of Calendula officinalis, 0.1...5% oil of Matricaria recutita, 0.1...2% tincture of Aesculus hippocastanum, 0.1...11% cocoa butter, 0.1...3% alcoholic extract of Capsella bursapastoris and 0.1...12% bee wax, the percentage being expressed by mass.
Patent AP-2004003060-A0 (AP)
Title: Valve assembly for use in dispensing beverage
Inventor: RAATS PAUL HENRI
IPC: B67C3/32
Filed: 2002-12-12
Abstract: A valve assembly for a container with an inner bag for receiving beverage, in particular carbonated beverage such as beer, wherein a beverage valve is provided with a communication with the inner space of the bag and means for operation of the beverage valve by a tapping device in which the container is receivable, the beverage valve being partly surrounded by an upstanding first apron which is gas-tight, while, spaced therefrom, a second gas-tight apron is situated, and between the first and the second apron a bottom wall with at least one gas passage opening is provided which during use is in communication with the space enclosed between the inner bag and the container, such that during use between the two aprons a chamber is formed through which gas under pressure can be forced through the gas passage opening, separately from the beverage.
Patent MC-2063-A1 (MC)
Inventor: GIOVANNI AZZIMONTI
IPC: E04B2/96
Filed: 1988-11-07
Abstract: PCT No. PCT/IT88/00081 Sec. 371 Date Jul. 9, 1990 Sec. 102(e) Date Jul. 9, 1990 PCT Filed Nov. 7, 1988 PCT Pub. No. WO89/04416 PCT Pub. Date May 18, 1989.This invention provides for the mechanical attachment of at least a strip (3) of glass or the like to the metal structure (1) (by using staples, for example, or other means of attachment) in such a way that the strip (3) of glass faces the area (14) where the sheet (4) of glass is fixed. The sheet (4) of glass, double or single glazed, is fixed to said strip (3) by an elastic means (5) for example silicon seals ideal for use in the normal fixing of glass to glass, Preferably, the metal structure comprises a jutting ledge (9) that acts as a support for the vertical forces acting on the sheet (4) of glass.
Patent MA-19023-A1 (MA)
Inventor: K FRANKENFELD
IPC: C22B60/02
Filed: 1980-12-23
Abstract: The invention concerns a method for the liquid/liquid extraction of uranium from phosphoric acid with the aid of alkylamine polyphosphate and/or alkylamine metaphosphate compounds, dissolved in organic solvents insoluble in water. The uraniferous phosphoric acid is brought into contact with an organic phase compound of a long-chain alkylamine polyphosphate and/or alkylamine metaphosphate compound and an organic solvent, the alkylamine in the alkyl residue containing 8 to 30, preferably 8 to 18 C-atoms corresponding to the formula <IMAGE>   wherein R1 and R2 denote hydrogen or alkyl radicals and R3 denotes an alkyl radical, the polyphosphate and/or metaphosphate residue having 2 to 10,000 P-atoms per molecule and being of the straight-chain and/or linked-chain or cyclic chain type. The uranium is transferred from the aqueous into the organic phase from which the uranium is re-extracted in the known way.
Patent MA-21760-A1 (MA)
IPC: B61L21/06
Filed: 1990-03-05
Abstract: In a control panel for an electronic switch tower, the track keyboard (13) contains only elements, namely track keys (14), which are used for issuing commands and are assigned in terms of position both to the illustrated track sections and are also arranged in a matrix and can be interrogated by line. Furthermore, the drive signal transmitted by a display computer (3) to the colour display device (11) contains, apart from  the signal for generating a compressed overview image (12), only the data relevant for displaying the track-free and track-occupied state by colour changes, the route and the train numbers. As a result, it is possible for switch tower areas to be operated with up to 80 sets of points by means of one track keyboard and to be capable of being illustrated on one colour display device. Only under specific brief operating conditions and in the event of a fault is the magnified image of the respective area of interest switched in a conventional manner to a second colour viewing device. <IMAGE>
Patent MA-24714-A1 (MA)
Inventor: TEN BOK MICHEL
IPC: B65D21/04
Filed: 1998-12-07
Abstract: The number of especially raw fish containers (1) are assembled to a stack in which they rotate to facilitate access. Liquid especially water from melting ice drains to the inner base (10) of the container. The base zone sidewalls (11, 12, 13, 14) of each container have drainage gullies which are open-topped for most of their length.   The holes (51, 52, 53, 54) in the sidewall discharge to the outer face of the container, where the water drains directly in contact with the container outer wall into the outer water capture gully of the container below. Water continues to drain down the container stack outer face until it reaches the ground for capture in a suitable vessel or drain.
Patent MA-27309-A1 (MA)
Title: Comprimes orodispersibles et processus pour les obtenir
Inventor: SEGADO FERRAN JAVIER
IPC: A61K47/36
Filed: 2004-12-06
Abstract: Les comprimés comprennent:  au moins 59,5% de mannitol séché par atomisation; l'ingrédient actif inférieur ou égal à 10%,  oé au moins  90% en poids de l'ingrédient actif a une dimension particulaire de moins de 100 Ám; de la cellulose microcristalline 10-18%, ayant une dimension particulaire moyenne de 50 Ám et oé au moins 99% en poids de la cellulose microcristalline ont une dimension particulaire au-dessous de 250 Ám; de la croscarmellose de sodium 1-4%; et un agent lubrifiant 0,5-2%; oé, sauf indication contraire, les pourcentages sont exprimés en poids du poids total du comprimé. Et aussi un processus comprenant:  le tamisage et le mélange des composants à l'exception de l'agent lubrifiant; le mélange de tous les composants; et la compression directe du mélange final. Les comprimés de l'invention diminuent les temps de désagrégation, donnent une bonne perception sur la langue après la désagrégation,  et surmontent le problème de la résistance mécanique insuffisante pour les opérations d'emballage et de transport.
Patent MA-27754-A1 (MA)
Title: Pyrimidinones substituees
Inventor: DURLEY RICHARD
IPC: C07D405/04
Filed: 2005-10-03
Abstract: Il est décrit des composés de formule I et leurs sels pharmaceutiquement acceptables, formule dans laquelle R1, R2, R4 et R5 répondent aux définitions figurant dans le présent mémoire. Ces composés sont utiles pour le traitement de maladies et d'affections provoquées ou exacerbées par une activité non-régulée de MAP kinase p38 et/ou de TNF. Des compositions pharmaceutiques contenant les composés, des procédés pour la préparation des composés et des méthodes de traitement utilisant les composés sont également décrits.
Patent MA-53070-A1 (MA)
Title: Un procédé biotechnologique de transformation des fientes de volaille en produit de fertilisation organique des sols agricoles
Inventor: MOUNAIM HALIM EL JALIL
IPC: C05F15/00
Filed: 2021-04-26
Abstract: La présente invention concerne un procédé biotechnologique pour l’hygiénisation, la désodorisation, la stabilisation des déchets de l’industrie avicole « fientes de volaille ». La biotransformation se fait sous l’action d’un ferment mixte probiotique de souches pures de bactéries lactiques et de levures. Le procédé permet l’obtention d’un produit exempt de polluants et de toxiques, riche en matière organique, en minéraux et en probiotiques, valorisable en tant que biofertilisation des sols agricoles.
Patent SG-89316-A1 (SG)
Title: Hybrid intrastromal corneal ring
Inventor: SILVESTRINI THOMAS A
IPC: A61F9/00
Filed: 1993-08-04
Abstract: This invention is an intrastromal corneal ring having comprising at least one outer layer of a physiologically compatible polymer having a low modulus of elasticity, which polymer may be hydratable and may be hydrophilic. The inner portion of the hybrid intrastromal corneal ring may be hollow or may contain one or more physiologically compatible polymers.
Patent UY-23239-A1 (UY)
Inventor: GARZA FLORES JOSUE
IPC: A61K9/00
Filed: 1991-06-13
Abstract: Non-porous solid microspheres have a dia. of 5-300 microns and consist of a mixt. of at least one injectable drug and a carrier. Provided the carrier is a substance naturally present in the recipient organism, it is stable in the solid state at temps. up to at least 60 deg. C and in the recipient physiological medium, and has dissolution kinetics in the recipient organism that are slower than the release kinetics of the drug in the same organism. Carrier is pref. coprosterol, glycocholic acid, cholesterol or a cholesterol este. Drug is pref. e.g, lorazepam, haloperidol, diazepam, biperiden, trihexyphenidyl.HCl, clonazepam, morphine, metoclopramide, acepromazine maleate, domperidone, vincamine etc. Microspheres are produced by dispersing the drug in the carrier, melting the mixt. in an inert gas atmos., spraying the melt under inert gas pressure, cooling the spray to solidify the droplets, and screening the resulting microspheres.
Patent UY-28007-A1 (UY)
Title: Tratamiento terapeutico
Inventor: OWEN CURWEN JON
IPC: A61K31/445
Filed: 2003-10-07
Abstract: Se describe el uso de un agonista del receptor de 5-HT1B/1D en el tratamiento o prevención del dolor de cabeza que resulta de la administración de un antagonista del receptor de endotelina; y la combinación, que comprende un antagonista del receptor de endotelina y un agonista del receptor de 5-HT1B/1D.
Patent UY-28374-A1 (UY)
Title: Agentes terapéuticos
Inventor: BERGGREN KRISTINA
IPC: A61P25/00
Filed: 2004-06-18
Abstract: La presente invención se refiere un compuesto de fórmula I y procesos para preparar tales compuestos, su uso en el tratamiento de obesidad, trastornos psiquiátricos y neurológicos, a métodos para uso terapéutico y a composiciones farmacéuticos que los contienen.